8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input
22 February 2022 · Example where medicines are prescribed by both the patient’s GP and specialist clinicians, and are administered in a patient’s home.
9 September 2020 · This Q&A provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
10 June 2021 · The below summary explains the legislation and guidance on the use of PGDs when a medicine is to be used outside its licence ('off-label')